Next-Generation Sequencing Technology In Oncology Drug Development |
By Onikepe Adegbola, M.D., Ph.D. In the decade since the completion of the human genome project, DNA sequencing technology has changed considerably. |
Bigger Isn't Always Better, Part II |
By Laurence P. Birch, Chairman and CEO, DATATRAK I read a discussion on LinkedIn recently where someone asked for feedback from the community of members on eClinical. The initial question focused on market share in the industry, by company. |
Creating Career GPS To Enhance Your Opportunities |
By Bill Donovan, Chief Source Officer, Chiltern Building a successful career in life sciences requires that you regularly measure and strengthen your professional value, but personal career development remains particularly challenging within this sector. |
Think Big: Shorten The Time Of Getting A Drug To Market |
| | By Rick Morrison, CEO, Comprehend Systems Pharma is constantly searching for ways to reduce the cost and time of getting a drug to market, and one way is to conduct innovative technology-supported, global clinical trials that harness the power of real-time data and insight. |
Reduce Risk And Raise Quality In Clinical Trials |
By BioClinica The massive amount of data that a clinical trial can yield is enough to give any team studying it difficulty in determining the data’s importance and meaning. This white paper offers guidelines on how to best translate the data collected into actionable results. |
댓글 없음:
댓글 쓰기